ALXO
ALX Oncology Announces Participation in the Jefferies Global Healthcare Conference
Wednesday, May 29, 2024 BiopharmaWatch Research 1 min read Key Takeaway: ALX Oncology Announces Participation in the Jefferies Global Healthcare Conference
Price reaction · baseline $12.56 (2024-05-28 close) · hit after-hours · 1 other ALXO headline(s) in the window, move may be shared
Conference Participation Details
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat
How to Access
Investors and the general public can listen to both sessions live at:
https://investor.viatris.com Archived versions will be available following the live events for a limited time.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+102%
120-day peak, hindsight
Typical move
7.9%
average across 6 past catalysts
Cash runway
~25 mo
Minimal dilution risk
Lead asset
ALX2004
Phase 1 · NSCLC (Advanced Non-small Cell Lung Cancer)
Full Press Release Details
ALX Oncology Announces Participation in the Jefferies Global Healthcare Conference.